Personal tools

FF:0000457: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{F5terms |id=FF:0000457 |name=MCF7 breast cancer cell line 8h after HRG treatment |namespace=FANTOM5 |def= |xref= |is_a=EFO:0001746;;FF:0000210;;FF:0000331;;FF:0000350;...")
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{F5terms
{{F5terms
|id=FF:0000457
|alt_id=
|name=MCF7 breast cancer cell line 8h after HRG treatment
|namespace=FANTOM5
|def=
|xref=
|is_a=EFO:0001746;;FF:0000210;;FF:0000331;;FF:0000350;;FF:0000365;;FF:0100093
|synonym=
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|adjacent_to=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=FF:0000457
|is_a=EFO:0001746 ;;FF:0000210 ;;FF:0000331 ;;FF:0000350 ;;FF:0000365 ;;FF:0100093
|is_obsolete=
|located_in=
|located_in=
|name=human MCF7 breast cancer cell line 8h after HRG treatment sample
|namespace=FANTOM5
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=
|property_value=
|is_obsolete=
|subset=
|preceded_by=
|synonym=
|union_of=
|xref=
}}
}}

Latest revision as of 16:56, 12 September 2014

outline

  • id: FF:0000457
  • name: human MCF7 breast cancer cell line 8h after HRG treatment sample
  • namespace: FANTOM5
  • CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:EFO:0001746(development or differentiation design),FF:0000210(human sample),FF:0000331(HRG treatment sample),FF:0000350(experimentally modified sample),FF:0000365(8 hr sample),FF:0100093(MCF-7 cell sample)

Children

is a:FF:13062-139I2 (MCF7 breast cancer cell line response to HRG),FF:13128-140G5 (MCF7 breast cancer cell line response to HRG),FF:13194-141E8 (MCF7 breast cancer cell line response to HRG)

FF Samples

Human

  • 13062-139I2 (MCF7 breast cancer cell line response to HRG)
  • 13128-140G5 (MCF7 breast cancer cell line response to HRG)
  • 13194-141E8 (MCF7 breast cancer cell line response to HRG)